Viewing Study NCT00903760


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2026-02-09 @ 12:45 AM
Study NCT ID: NCT00903760
Status: COMPLETED
Last Update Posted: 2018-11-15
First Post: 2009-05-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelodysplastic Syndrome View
None MDS View
None Leukemia View
None Decitabine View
None clofarabine View
None Dacogen® View
None Clolar® View